ABC | Volume 111, Nº3, September 2018

Short Editorial Mariani Junior Adiponectin and IVUS-VH Coronary Plaque Characteristics Arq Bras Cardiol. 2018; 111(3):354-355 1. GermolecDR, Shipkowski KA, Frawley RP, Evans E. Markers of Inflammation. Methods Mol Biol. 2018;1803:57-79 2. deBoerSP,ChengJM,Garcia-GarciaHM,OemrawsinghRM,vanGeunsRJ,Regar E,etal.Relationofgeneticprofileandnovelcirculatingbiomarkerswithcoronary plaquephenotypeasdeterminedbyintravascularultrasound:rationaleanddesign oftheATHEROREMO-IVUSstudy.EuroIntervention.2014;10(8):953-60. 3. KolevaDI, OrbetzovaMM, Nikolova JG, Deneva TI. Pathophysiological role of adiponectin, leptin and asymmetric dimethylarginine in the process of atherosclerosis. Folia Med (Plovdiv). 2016;58(4):234-40. 4. Iberale L, Carbone F, Bertolotto M, Bonaventura A, Vecchié A, Mach F, Burger F, Pende A, Spinella G, Pane B, Palombo D, Dallegri F, Montecucco F. Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis. Vascul Pharmacol. 2018 Mar;102:37-43. 5. Marino BCA, Buljubasic N, Akkerhuis M, Cheng JM, Garcia-Garcia HM, Regar E. Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular Outcome. Arq Bras Cardiol. 2018; 111(3):345-353. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 355